129
Views
0
CrossRef citations to date
0
Altmetric
Epidemiology

Analysis of the spatial distribution of amyotrophic lateral sclerosis in Virginia

, , , , , , , & show all
Pages 669-677 | Received 20 Mar 2023, Accepted 30 Jun 2023, Published online: 14 Jul 2023

References

  • Logroscino G, Piccininni M, Marin B, Nichols E, Abd-Allah F, Abdelalim A, et al. Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:1083–97.
  • Marin B, Boumédiene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46:57–74.
  • Mitsumoto H, Chad DA, Pioro EP. Amyotrophic lateral sclerosis. USA: Oxford University Press; 1998.
  • Brenner D, Freischmidt A. Update on genetics of amyotrophic lateral sclerosis. Curr Opin Neurol. 2022;35:672–7.
  • Dion PA, Daoud H, Rouleau GA. Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat Rev Genet. 2009;10:769–82.
  • Ajroud-Driss S, Siddique T. Sporadic and hereditary amyotrophic lateral sclerosis (ALS). Biochim Biophys Acta. 2015;1852:679–84.
  • Ghasemi M, Brown RH. Genetics of amyotrophic lateral sclerosis. Cold Spring Harbor Perspectives in Medicine 2018;8:a024125.
  • Povedano M, Saez M, Martinez-Matos JA, Barceló MA. Spatial assessment of the association between long-term exposure to environmental factors and the occurrence of amyotrophic lateral sclerosis in Catalonia, Spain: a population-based nested case-control study. Neuroepidemiology 2018;51:33–49.
  • Andrew A, Zhou J, Gui J, Harrison A, Shi X, Li M, et al. Pesticides applied to crops and amyotrophic lateral sclerosis risk in the US. Neurotoxicology 2021;87:128–35.
  • Caller TA, Field NC, Chipman JW, Shi X, Harris BT, Stommel EW. Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA. Amyotroph Lateral Scler. 2012;13:25–32.
  • Carmichael W. A world overview—one-hundred-twenty-seven years of research on toxic cyanobacteria—where do we go from here?. In: Kenneth Hudnell H, ed. Cyanobacterial harmful algal blooms: State of the science and research needs.Triangle Park, NC, USA: United States Environmental Protection Agency; 2008:105–25.
  • Spencer PS, Lagrange E, Camu W. ALS and environment: clues from spatial clustering? Rev Neurol (Paris). 2019;175:652–63.
  • Garruto RM. Amyotrophic lateral sclerosis and parkinsonism-dementia of Gaum: Clinical, epidemiological, and genetic patterns. Am J Hum Biol. 1989;1:367–82.
  • Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9:617–28.
  • Weisskopf MG, O’Reilly EJ, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, et al. Prospective study of military service and mortality from ALS. Neurology 2005;64:32–7.
  • Haley RW. Excess incidence of ALS in young Gulf War veterans. Neurology 2003;61:750–6.
  • Coffman CJ, Horner RD, Grambow SC, Lindquist J, VA Cooperative Studies Program Project #500. Estimating the occurrence of amyotrophic lateral sclerosis among Gulf War (1990–1991) veterans using capture-recapture methods. Neuroepidemiology 2005;24:141–50.
  • Deapen DM, Henderson BE. A case-control study of amyotrophic lateral sclerosis. Am J Epidemiol. 1986;123:790–9.
  • Kamel F, Umbach DM, Hu H, Munsat TL, Shefner JM, Taylor JA, et al. Lead exposure as a risk factor for amyotrophic lateral sclerosis. Neurodegener Dis. 2005;2:195–201.
  • Kamel F, Umbach DM, Lehman TA, Park LP, Munsat TL, Shefner JM, et al. Amyotrophic lateral sclerosis, lead, and genetic susceptibility: polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genes. Environ Health Perspect. 2003;111:1335–9.
  • Mitsumoto H, Factor-Litvak P, Andrews H, Goetz RR, Andrews L, Rabkin JG, et al. ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:192–203.
  • Pupillo E, Messina P, Logroscino G, Zoccolella S, Chiò A, Calvo A, et al. Trauma and amyotrophic lateral sclerosis: a case–control study from a population-based registry. Eur J Neurol. 2012;19:1509–17.
  • Wang H, O’Reilly ÉJ, Weisskopf MG, Logroscino G, McCullough ML, Thun MJ, et al. Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. Arch Neurol. 2011;68:207–13.
  • Fang F, Valdimarsdóttir U, Bellocco R, Ronnevi LO, Sparén P, Fall K, et al. Amyotrophic lateral sclerosis in Sweden, 1991-2005. Arch Neurol. 2009;66:515–9.
  • Taylor JA, Davis JP. Evidence for clustering of amyotrophic lateral sclerosis in Wisconsin. J Clin Epidemiol. 1989;42:569–75.
  • Proctor SP, Feldman RG, Wolf PA, Brent B, Wartenberg D. A perceived cluster of amyotrophic lateral sclerosis cases in a Massachusetts community. Neuroepidemiology 1992;11:277–81.
  • Henry KA, Fagliano J, Jordan HM, Rechtman L, Kaye WE. Geographic variation of amyotrophic lateral sclerosis incidence in New Jersey, 2009–2011. Am J Epidemiol. 2015;182:512–9.
  • Migliaretti G, Berchialla P, Dalmasso P, Cavallo F, Chiò A. Amyotrophic lateral sclerosis in Piedmont (Italy): a Bayesian spatial analysis of the incident cases. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:58–65.
  • Vieira VM, Hansen J, Gredal O, Weisskopf MG. Spatial analyses of ALS incidence in Denmark over three decades. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:275–84.
  • Bradley WG, Mash DC. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Amyotroph Lateral Scler. 2009;10 Suppl 2:7–20.
  • Johnson FO, Atchison WD. The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis. Neurotoxicology 2009;30:761–5.
  • Mehta P, Raymond J, Punjani R, Larson T, Han M, Bove F, et al. Incidence of amyotrophic lateral sclerosis in the united states, 2014–2016. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:378–82.
  • Bureau USC. 2015–2019 American Community Survey 5-Year Estimates. 2019.
  • Mayo Clinic. Amyotrophic lateral sclerosis (ALS) [Internet]. 2022. Available at: https://www.mayoclinic.org/diseases-conditions/amyotrophic-lateral-sclerosis/symptoms-causes/syc-20354022
  • Horton DK, Graham S, Punjani R, Wilt G, Kaye W, Maginnis K, et al. A spatial analysis of amyotrophic lateral sclerosis (ALS) cases in the United States and their proximity to multidisciplinary ALS clinics, 2013. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:126–33.
  • Wagner L, Rechtman L, Jordan H, Ritsick M, Sanchez M, Sorenson E, et al. State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:128–34.
  • Rechtman L, Jordan H, Wagner L, Horton DK, Kaye W. Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:65–71.
  • United States Geological Survey. Estimated annual agricultural pesticide use [Internet]. National Water-Quality Assessment Project; 2021. Reston (VA): USGS. Available at: water.usgs.gov/nawqa/pnsp/usage/maps/county-level
  • Besag J, York J, Mollié A. Bayesian image restoration, with two applications in spatial statistics. Ann Inst Stat Math. 1991;43:1–20.
  • R Core Team, Others. R: A language and environment for statistical computing. Vienna, Austria: R foundation for statistical computing; 2021.
  • Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS—a Bayesian modelling framework: Concepts, structure, and extensibility. Stat Comput. 2000;10:325–37.
  • Sturtz S, Ligges U, Gelman A. R2WinBUGS: a package for running WinBUGS from R. J Stat Soft. 2005;12:1–16.
  • Gelman A, Rubin DB. Inference from iterative simulation using multiple sequences. Statist Sci. 1992;7:457–72.
  • MRC. DIC: Deviance information criteria [Internet]. University of Cambridge Biostatistics Unit. Cambridge: Cambridge University Press; 2022. Available at: https://www.mrc-bsu.cam.ac.uk/software/bugs/the-bugs-project-dic/
  • Lawson AB. Bayesian disease mapping: hierarchical modeling in spatial epidemiology. Boca Raton (FL): Chapman and Hall/CRC; 2018.
  • Nelson LM. Epidemiology of ALS. Clin Neurosci. (New York, NY). 1995;3(6):327–31.
  • Mitchell JD. Amyotrophic lateral sclerosis: toxins and environment. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:235–50.
  • Riggs JE. Trauma, axonal injury, and amyotrophic lateral sclerosis: a clinical correlate of a neuropharmacologic model. Clin Neuropharmacol. 1995;18:273–6.
  • Strickland D, Smith SA, Dolliff G, Goldman L, Roelofs RI. Physical activity, trauma, and ALS: a case-control study. Acta Neurol Scand. 1996;94:45–50.
  • Longstreth WT, McGuire V, Koepsell TD, Wang Y, Van Belle G. Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case-control study. Arch Neurol. 1998;55:201–6.
  • Fang F, Kwee LC, Allen KD, Umbach DM, Ye W, Watson M, et al. Association between blood lead and the risk of amyotrophic lateral sclerosis. Am J Epidemiol. 2010;171:1126–33.
  • Domico LM, Cooper KR, Bernard LP, Zeevalk GD. Reactive oxygen species generation by the ethylene-bis-dithiocarbamate (EBDC) fungicide mancozeb and its contribution to neuronal toxicity in mesencephalic cells. Neurotoxicology 2007;28:1079–91.
  • Iorio R, Castellucci A, Rossi G, Cinque B, Cifone MG, Macchiarelli G, et al. Mancozeb affects mitochondrial activity, redox status and ATP production in mouse granulosa cells. Toxicol in Vitro. 2015;30:438–45.
  • Mostafalou S, Abdollahi M. Pesticides and human chronic diseases: evidences, mechanisms, and perspectives. Toxicol Appl Pharmacol. 2013;268:157–77.
  • Mills PK, Dodge JL, Bush J, Thompson Y, Shah P. Agricultural exposures and breast cancer among Latina in the San Joaquin Valley of California. J Occup Environ Med. 2019;61:552–8.
  • Mostafalou S, Abdollahi M. Pesticides: an update of human exposure and toxicity. Arch Toxicol. 2017;91:549–99.
  • Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181–93.
  • ALS Association. ALS Association [Internet]. 2022. Available at: http://als.org. Accessed October 10, 2022.
  • Public Health Service US. ALS Registry Act. Washington, DC: US Congress; 2008; p. L 1130-373 42 USC 280g-7.
  • Antao VC, Horton DK. The national amyotrophic lateral sclerosis (ALS) registry. J Environ Health. 2012;75:28.
  • Nelson LM, Topol B, Kaye W, Raymond J, Horton DK, Mehta P, et al. Evaluation of the completeness of ALS Case Ascertainment in the US National ALS Registry: application of the capture-recapture method. Neuroepidemiology 2022;56:104–14.
  • Mehta P, Raymond J, Punjani R, Han M, Larson T, Kaye W, et al. Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017. Amyotroph Lateral Scler Frontotemporal Degener. 2023;24:108–16.
  • Turabelidze G, Zhu BP, Schootman M, Malone JL, Horowitz S, Weidinger J, et al. An epidemiologic investigation of amyotrophic lateral sclerosis in Jefferson County, Missouri, 1998–2002. Neurotoxicology 2008;29:81–6.
  • Boyle J, Ward MH, Koutros S, Karagas MR, Schwenn M, Silverman D, et al. Estimating cumulative spatial risk over time with low-rank kriging multiple membership models. Stat Med. 2022;41:4593–606.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.